Edition:
United Kingdom

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

3.74USD
19 Oct 2018
Change (% chg)

$0.02 (+0.54%)
Prev Close
$3.72
Open
$3.71
Day's High
$3.76
Day's Low
$3.71
Volume
4,546
Avg. Vol
15,885
52-wk High
$3.80
52-wk Low
$1.20

Chart for

About

Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $70.64
Shares Outstanding(Mil.): 24.36
Dividend: --
Yield (%): --

Financials

  CHMA.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -1.28 -- --
ROI: -34.47 14.75 14.27
ROE: -35.41 16.24 15.99

BRIEF-Chiasma Announces FDA Agreement To Redefine Certain Secondary Endpoints In Phase 3 Clinical Trial

* CHIASMA ANNOUNCES FDA AGREEMENT TO REDEFINE CERTAIN SECONDARY ENDPOINTS IN CHIASMA OPTIMAL PHASE 3 CLINICAL TRIAL

14 May 2018

Earnings vs. Estimates